Discover how scientists are using CRISPR-loaded extracellular vesicles as Trojan horses to target and destroy osteosarcoma bone cancer cells with precision.
Discover how CRISPR-Cas9 technology is revolutionizing lung cancer research by identifying genetic vulnerabilities in EGFR-mutant non-small cell lung cancer cells.
Discover how the ATXN3 protein regulates PD-L1 in cancer cells and enables tumor immune evasion through CRISPR screening research.